Can a simple conversation prevent deadly blood clots?
NCT ID NCT06731244
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a shared decision-making process, which uses personalized risk scores, can help patients with unprovoked blood clots choose the best duration of blood-thinning medication. The goal is to reduce the chance of another clot or serious bleeding while improving patient satisfaction. About 2,400 adults who have had a first unprovoked clot will be randomly assigned to usual care or the shared decision-making approach.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- shared decision-making process
- What this could lead to
- If successful, this approach could help patients and doctors choose the right duration of blood-thinning therapy, reducing the risk of another clot or serious bleeding.
- What could go wrong
- This is a large but early-stage study testing a decision-making process, not a drug. The results may not change current practice if the intervention does not clearly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHM - Hôpital la Timone
NOT_YET_RECRUITINGMarseille, 13005, France
-
APHP-Colombes
NOT_YET_RECRUITINGColombes, 92700, France
-
Aphp-Hegp
NOT_YET_RECRUITINGParis, 75015, France
-
Aphp-Hegp
NOT_YET_RECRUITINGParis, 75015, France
-
CH Le Mans
NOT_YET_RECRUITINGLe Mans, 72037, France
-
CHU Brest
RECRUITINGBrest, France, 29609, France
-
CHU Saint Etienne
NOT_YET_RECRUITINGSaint-Etienne, 42270 Saint Priest En Jarez, France
-
CHU d'Amiens - Picardie
NOT_YET_RECRUITINGAmiens, 80054, France
-
CHU d'Angers
NOT_YET_RECRUITINGAngers, 49933, France
-
CHU de Clermont Ferrand
NOT_YET_RECRUITINGClermont-Ferrand, 63000, France
-
CHU de Dijon - Hôpital François Mitterand
NOT_YET_RECRUITINGDijon, 21079, France
-
CHU de Montpellier
NOT_YET_RECRUITINGMontpellier, 34295, France
-
CHU de Nancy
NOT_YET_RECRUITINGNancy, 54511, France
-
CHU de Nantes
NOT_YET_RECRUITINGNantes, 44093, France
-
CHU de Nîmes
NOT_YET_RECRUITINGNîmes, 30029, France
-
CHU de Rennes
NOT_YET_RECRUITINGRennes, 35200, France
-
CHU de Strasbourg
NOT_YET_RECRUITINGStrasbourg, 67091, France
-
CHU de Toulouse
NOT_YET_RECRUITINGToulouse, 31000, France
-
HCL - Hôpital Edouard Herriot
NOT_YET_RECRUITINGLyon, 69003, France
-
Hôpital National d'Instruction des Armées Percy
NOT_YET_RECRUITINGClamart, 92140, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could tailored blood thinner dosing prevent strokes in chinese patients?
- Could a simple aspirin pill replace daily shots to prevent postpartum blood clots?
- Simple 5-Step nursing plan could slash deadly clot risk after hip surgery
- Timing of blood thinners after childbirth bleeding may prevent clots without causing more harm
- Shorter blood thinner course after birth may be just as safe
- New scan may predict dangerous clot return in lung patients